Abstract - Neurophysiology Research (2020) Volume 0, Issue 0

Interest of screening and management for sleep disorders in the drug-resistant depressive syndrome

During the last two years, in a multidisciplinary psychiatric practice, a psychiatrist assisted with a sleep therapist decided to demonstrate that the management of secondary insomnia (induced by sleep apnea/hypopnea syndrome (SAHS)) and some other primary sleep disorders, with specific sleep therapy can reduce or sometimes even stop antidepressant treatments when a well-defined protocol is followed. Their results confirmed that in some of their patients there may be SAHS in drug-resistant depressions. This point out the fact any depression syndromes are due to or aggravated by insomnia induced by SAHS. Taking care of it may replace antidepressants.

Author(s): Eric Neuman

Abstract PDF